Ultra-rare Disease and Genomics-Driven Precision Medicine

Area of Science:

• Genomic Medicine
• Clinical Genetics

Background:

• Next-generation sequencing (NGS) adoption has revolutionized rare genetic disease diagnosis.
• Genomic medicine translates genetic insights into personalized patient management.
• Successful molecular diagnoses and targeted therapies for rare genetic diseases have been reported.

Purpose of the Study:

• To review the impact of NGS on rare genetic disease diagnosis.
• To identify challenges in applying NGS-based precision medicine.
• To highlight the need for further advancements in treatment options.

Main Methods:

• Literature review of NGS applications in rare genetic diseases.
• Analysis of successful case reports and clinical practice adoption.
• Identification of current limitations and obstacles.

Main Results:

• NGS has significantly improved the diagnosis of rare genetic disorders.
• Personalized and targeted therapies show promise in managing these conditions.
• Obstacles include high sequencing costs, accuracy issues, and treatment scarcity.

Conclusions:

• NGS is a powerful tool for rare genetic disease diagnosis and precision medicine.
• Overcoming current challenges is crucial for broader clinical implementation.
• Further research into cost reduction and novel therapeutic strategies is warranted.